Commentary: What pooling data tells us, or not, about using TAVR in the population at low surgical risk for mortality

Moritz C. Wyler von Ballmoos, Michael J. Reardon

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalCardiovascular Revascularization Medicine
DOIs
StateAccepted/In press - Jan 1 2020

Keywords

  • Generalizibility
  • Low-risk
  • Randomized trials
  • SAVR
  • TAVR

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this